Podcast Interview: Harvey Berger, CEO, ARIAD Pharmaceuticals

June 30, 0011

Pharmaceutical Executive

Harvey Berger, CEO at ARIAD Pharmaceuticals, discusses commercial strategy and his deal with Merck on a Phase 3 cancer drug.

Interview: Harvey Berger

Harvey Berger, CEO at ARIAD Pharmaceuticals, discusses his deal with Merck on riduforolimus, a cancer drug in Phase 3, and ARIAD's commercialization strategy going forward.